Neprilysin as a Biomarker: Challenges and Opportunities by Noemi Pavo, Suriya Prausmüller, Philipp E Bartko, Georg Goliasch, Martin Hülsmann

Get full text

The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction by Andreas Hammer, Patrick Sulzgruber, Lorenz Koller, Niema Kazem, Felix Hofer, Bernhard Richter, Steffen Blum, Martin Hülsmann, Johann Wojta, Alexander Niessner

Get full text

Impaired High‐Density Lipoprotein Anti‐Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure by Lore Schrutka, Klaus Distelmaier, Philipp Hohensinner, Patrick Sulzgruber, Irene M. Lang, Gerald Maurer, Johann Wojta, Martin Hülsmann, Alexander Niessner, Lorenz Koller

Get full text

Eligibility and GDMT up-titration success in heart failure: A real-world assessment. by Annika Weidenhammer, Suriya Prausmüller, Marc Stadler, Noel Panagiotides, Georg Spinka, Gregor Heitzinger, Henrike Arfsten, Guido Strunk, Anush Barkhudaryan, Clemens Partsch, Philipp Bartko, Georg Goliasch, Christian Hengstenberg, Martin Hülsmann, Noemi Pavo

Get full text

Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy by Christopher Mann, MD, Ulrike Pailer, MSc, Andreas Spannbauer, MD, Fardin Hamidi, MD, Aliza Veronika Braser, Martin Hülsmann, MD, Christian Gerges, MD, PhD, Michael Gottsauner-Wolf, MD, Mariann Gyöngyösi, MD, Markus Raderer, MD, Martin Riesenhuber, MD, PhD, Christian Hengstenberg, MD, Jutta Bergler-Klein, MD, Thomas A. Zelniker, MD, MSc

Get full text